A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 3.8 NZD with a low forecast of 3.03 NZD and a high forecast of 4.67 NZD.

Lowest
Price Target
3.03 NZD
7% Upside
Average
Price Target
3.8 NZD
34% Upside
Highest
Price Target
4.67 NZD
65% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets
TORNTPHARM
Torrent Pharmaceuticals Ltd
4% Upside
4565
Sosei Group Corp
105% Upside
4577
Daito Pharmaceutical Co Ltd
41% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
27% Upside
DPHARMA
Duopharma Biotech Bhd
18% Upside
PPLPHARMA
Piramal Pharma Ltd
12% Upside
SNT
Syntara Ltd
101% Upside
PHO
Photocure ASA
59% Upside

Revenue
Forecast

Revenue Estimate
AFT Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 14%.

15%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 12%.

N/A
Past Growth
12%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 23%.

N/A
Past Growth
23%
Estimated Growth
Estimates Accuracy
7%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFT's stock price target?
Price Target
3.8 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 3.8 NZD with a low forecast of 3.03 NZD and a high forecast of 4.67 NZD.

What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 14%.

What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
12%

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 12%.

What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
23%

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 23%.

Back to Top